SIRT1 protects rat lung tissue against severe burn-induced remote ALI by attenuating the apoptosis of PMVECs via p38 MAPK signaling

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Bai, Xiaozhi ^a   Fan, Lei ^a   He, Ting ^a   Jia, Wenbin ^a   Yang, Longlong ^a   Zhang, Jun ^b   Liu, Yang ^a   Shi, Jihong ^a   Su, Linlin ^a   Hu, Dahai ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b The 205th Hospital of People s Liberation Army   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYTOKINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; RESVERATROL; SIRT1 PROTEIN, RAT; SIRTUIN 1; SMALL INTERFERING RNA; STILBENE DERIVATIVE;

ACUTE LUNG INJURY; ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; BURN; CELL CULTURE; COMPLICATION; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; ENDOTHELIUM CELL; GENETICS; LUNG; MALE; METABOLISM; PATHOLOGY; PERMEABILITY; RAT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ACUTE LUNG INJURY; ANIMALS; APOPTOSIS; BURNS; CASPASE 3; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; LUNG; MALE; MAP KINASE SIGNALING SYSTEM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SIRTUIN 1; STILBENES;

EID: 84930216339     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10277     Document Type: Article

References (56)

1. Parihar, A., Parihar, M. S., Milner, S. & Bhat, S. Oxidative stress and anti-oxidative mobilization in burn injury. Burns 34, 6-17, doi:10.1016/j.burns.2007.04.009 (2008).
2. Schmid, E. et al. Requirement for C5a in lung vascular injury following thermal trauma to rat skin. Shock 8, 119-124 (1997).
3. Fang, Y. et al. Hydrogen-rich saline protects against acute lung injury induced by extensive burn in rat model. Journal of burn care & research : ofcial publication of the American Burn Association 32, e82-91, doi:10.1097/BCR.0b013e318217f84f (2011).
4. Fang, Y. et al. Ulinastatin improves pulmonary function in severe burn-induced acute lung injury by attenuating infammatory response. The Journal of trauma 71, 1297-1304, doi:10.1097/TA.0b013e3182127d48 (2011).
5. Kitamura, Y. et al. Acute lung injury associated with systemic infammatory response syndrome following subarachnoid hemorrhage: a survey by the Shonan Neurosurgical Association. Neurologia medico-chirurgica 50, 456-460 (2010).
6. Lange, M. et al. Assessment of vascular permeability in an ovine model of acute lung injury and pneumonia-induced Pseudomonas aeruginosa sepsis. Critical care medicine 36, 1284-1289, doi:10.1097/CCM.0b013e318169ef74 (2008).
7. Jonkam, C. C. et al. Pulmonary vascular permeability changes in an ovine model of methicillin-resistant Staphylococcus aureus sepsis. Critical care 13, R19, doi:10.1186/cc7720 (2009).
8. Finkel, T., Deng, C. X. & Mostoslavsky, R. Recent progress in the biology and physiology of sirtuins. Nature 460, 587-591, doi:10.1038/nature08197 (2009).
9. Frye, R. A. Phylogenetic classifcation of prokaryotic and eukaryotic Sir2-like proteins. Biochemical and biophysical research communications 273, 793-798, doi:10.1006/bbrc.2000.3000 (2000).
10. Vaziri, H. et al. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107, 149-159 (2001).
11. Cohen, H. Y. et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305, 390-392, doi:10.1126/science.1099196 (2004).
12. Daitoku, H. et al. Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proceedings of the National Academy of Sciences of the United States of America 101, 10042-10047, doi:10.1073/pnas.0400593101 (2004).
13. Haigis, M. C. & Sinclair, D. A. Mammalian sirtuins: biological insights and disease relevance. Annual review of pathology 5, 253-295, doi:10.1146/annurev.pathol.4.110807.092250 (2010).
14. Howitz, K. T. et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191-196, doi:10.1038/nature01960 (2003).
15. Baur, J. A. & Sinclair, D. A. Terapeutic potential of resveratrol: the in vivo evidence. Nature reviews. Drug discovery 5, 493-506, doi:10.1038/nrd2060 (2006).
16. Frankel, E. N., Waterhouse, A. L. & Kinsella, J. E. Inhibition of human LDL oxidation by resveratrol. Lancet 341, 1103-1104 (1993).
17. Jang, M. et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275, 218-220 (1997).
18. Brakenhielm, E., Cao, R. & Cao, Y. Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB journal : ofcial publication of the Federation of American Societies for Experimental Biology 15, 1798-1800 (2001).
19. Winnik, S., Stein, S. & Matter, C. M. SIRT1-an anti-infammatory pathway at the crossroads between metabolic disease and atherosclerosis. Current vascular pharmacology 10, 693-696 (2012).
20. Wang, Q. et al. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain research 958, 439-447 (2002).
21. Rieder, S. A., Nagarkatti, P. & Nagarkatti, M. Multiple anti-infammatory pathways triggered by resveratrol lead to amelioration of staphylococcal enterotoxin B-induced lung injury. British journal of pharmacology 167, 1244-1258, doi:10.1111/j. 1476-5381.2012.02063.x (2012).
22. Xia, L., Ding, F., Zhu, J. H. & Fu, G. S. Resveratrol attenuates apoptosis of pulmonary microvascular endothelial cells induced by high shear stress and proinfammatory factors. Human cell 24, 127-133, doi:10.1007/s13577-011-0031-2 (2011).
23. Gloor, B. et al. Kupfer cell blockade reduces hepatic and systemic cytokine levels and lung injury in hemorrhagic pancreatitis in rats. Pancreas 21, 414-420 (2000).
24. Guo, F. et al. Management of burns of over 80% of total body surface area: a comparative study. Burns 35, 210-214, doi:10.1016/j. burns.2008.05.021 (2009).
25. Ryan, C. M. et al. Objective estimates of the probability of death from burn injuries. The New England journal of medicine 338, 362-366, doi:10.1056/NEJM199802053380604 (1998).
26. Maybauer, M. O., Rehberg, S., Traber, D. L., Herndon, D. N. & Maybauer, D. M. [Pathophysiology of acute lung injury in severe burn and smoke inhalation injury]. Der Anaesthesist 58, 805-812, doi:10.1007/s00101-009-1560-x (2009).
27. Marko, P., Layon, A. J., Caruso, L., Mozingo, D. W. & Gabrielli, A. Burn injuries. Current opinion in anaesthesiology 16, 183-191 (2003).
28. Monafo, W. W. Initial management of burns. The New England journal of medicine 335, 1581-1586, doi:10.1056/NEJM199611213352108 (1996).
29. Turnage, R. H. et al. Mechanisms of pulmonary microvascular dysfunction during severe burn injury. World journal of surgery 26, 848-853, doi:10.1007/s00268-002-4063-3 (2002).
30. Burns, A. R., Smith, C. W. & Walker, D. C. Unique structural features that infuence neutrophil emigration into the lung. Physiological reviews 83, 309-336, doi:10.1152/physrev.00023.2002 (2003).
31. Park, W. Y. et al. Cytokine balance in the lungs of patients with acute respiratory distress syndrome. American journal of respiratory and critical care medicine 164, 1896-1903, doi:10.1164/ajrccm.164.10.2104013 (2001).
32. Orfanos, S. E., Mavrommati, I., Korovesi, I. & Roussos, C. Pulmonary endothelium in acute lung injury: from basic science to the critically ill. Intensive care medicine 30, 1702-1714, doi:10.1007/s00134-004-2370-x (2004).
33. Bardales, R. H., Xie, S. S., Schaefer, R. F. & Hsu, S. M. Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. The American journal of pathology 149, 845-852 (1996).
34. Hotchkiss, R. S. et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Critical care medicine 27, 1230-1251 (1999).
35. Kawasaki, M. et al. Protection from lethal apoptosis in lipopolysaccharide-induced acute lung injury in mice by a caspase inhibitor. The American journal of pathology 157, 597-603, doi:10.1016/S0002-9440(10)64570-1 (2000).
36. Rudkowski, J. C. et al. Roles of iNOS and nNOS in sepsis-induced pulmonary apoptosis. American journal of physiology. Lung cellular and molecular physiology 286, L793-800, doi:10.1152/ajplung.00266.2003 (2004).
37. Hotchkiss, R. S. et al. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nature immunology 1, 496-501, doi:10.1038/82741 (2000).
38. Hoshi, T. et al. Immunohistochemistry of Caspase3/CPP32 in human stomach and its correlation with cell proliferation and apoptosis. Anticancer research 18, 4347-4353 (1998).
39. Lee, Y. M. et al. The role of sirtuin 1 in osteoblastic diferentiation in human periodontal ligament cells. Journal of periodontal research 46, 712-721, doi:10.1111/j.1600-0765.2011.01394.x (2011).
40. Lee, S. I. et al. Role of SIRT1 in heat stress-and lipopolysaccharide-induced immune and defense gene expression in human dental pulp cells. Journal of endodontics 37, 1525-1530, doi:10.1016/j.joen.2011.07.006 (2011).
41. Kim, Y. S., Lee, Y. M., Park, J. S., Lee, S. K. & Kim, E. C. SIRT1 modulates high-mobility group box 1-induced osteoclastogenic cytokines in human periodontal ligament cells. J Cell Biochem 111, 1310-1320, doi:10.1002/jcb.22858 (2010).
42. Park, G. J. et al. Efects of sirtuin 1 activation on nicotine and lipopolysaccharide-induced cytotoxicity and infammatory cytokine production in human gingival fbroblasts. Journal of periodontal research 48, 483-492, doi:10.1111/jre.12030 (2013).
43. Du, G. et al. Simvastatin attenuates TNFalphainduced apoptosis in endothelial progenitor cells via the upregulation of SIRT1. International journal of molecular medicine 34, 177-182, doi:10.3892/ijmm.2014.1740 (2014).
44. Galani, V. et al. The role of apoptosis in the pathophysiology of Acute Respiratory Distress Syndrome (ARDS): an up-to-date cell-specifc review. Pathology, research and practice 206, 145-150, doi:10.1016/j.prp.2009.12.002 (2010).
45. Csiszar, A. et al. Vasoprotective efects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinfammatory phenotypic alterations. American journal of physiology. Heart and circulatory physiology 294, H2721-2735, doi:10.1152/ajpheart.00235.2008 (2008).
46. Knobloch, J. et al. Resveratrol attenuates the release of infammatory cytokines from human bronchial smooth muscle cells exposed to lipoteichoic acid in chronic obstructive pulmonary disease. Basic & clinical pharmacology & toxicology 114, 202-209, doi:10.1111/bcpt.12129 (2014).
47. Kao, C. L. et al. Resveratrol protects human endothelium from H(2)O(2)-induced oxidative stress and senescence via SirT1 activation. Journal of atherosclerosis and thrombosis 17, 970-979 (2010).
48. Yang, S. R. et al. Sirtuin regulates cigarette smoke-induced proinfammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic infammation and aging. American journal of physiology. Lung cellular and molecular physiology 292, L567-576, doi:10.1152/ajplung.00308.2006 (2007).
49. Becatti, M. et al. SIRT1 modulates MAPK pathways in ischemic-reperfused cardiomyocytes. Cellular and molecular life sciences: CMLS 69, 2245-2260, doi:10.1007/s00018-012-0925-5 (2012).
50. Bao, X. M., Wu, C. F. & Lu, G. P. Atorvastatin attenuates homocysteine-induced apoptosis in human umbilical vein endothelial cells via inhibiting NADPH oxidase-related oxidative stress-triggered p38MAPK signaling. Acta pharmacologica Sinica 30, 1392-1398, doi:10.1038/aps.2009.135 (2009).
51. Uruno, A. et al. Stimulatory Efects of Low-Dose 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor Fluvastatin on Hepatocyte Growth Factor-Induced Angiogenesis: Involvement of p38 Mitogen-Activated Protein Kinase. Hypertens Res 31, 2085-2096 (2008).
52. Zhang, J. P. et al. Apoptosis in cardiac myocytes during the early stage afer severe burn. Journal Of Trauma-Injury Infection And Critical Care 65, 401-408, doi:Doi 10.1019/Ta.0b013e31817cf732 (2008).
53. Zhang, W. F. et al. Intensive insulin treatment attenuates burn-initiated acute lung injury in rats: role of the protective endothelium. Journal of burn care & research : ofcial publication of the American Burn Association 32, e51-58, doi:10.1097/BCR.0b013e318217f8ae (2011).
54. Liang, X. et al. Sodium butyrate protects against severe burn-induced remote acute lung injury in rats. PloS one 8, e68786, doi:10.1371/journal.pone.0068786 (2013).
55. Chen, S. F., Fei, X. & Li, S. H. A new simple method for isolation of microvascular endothelial cells avoiding both chemical and mechanical injuries. Microvascular research 50, 119-128, doi:10.1006/mvre.1995.1044 (1995).
56. You, Q. H., Sun, G. Y., Wang, N., Shen, J. L. & Wang, Y. Interleukin-17F-induced pulmonary microvascular endothelial monolayer hyperpermeability via the protein kinase C pathway. The Journal of surgical research 162, 110-121, doi:10.1016/j.jss.2009.01.019 (2010).